$98.85
-3.84 (-3.74%)
At Close: Jun 03, 2026
Herbal Dispatch Obtains Export Development Canada (EDC) Insurance to Support Accelerating International Growth
05:01am, Tuesday, 26'th May 2026
Vancouver, British Columbia--(Newsfile Corp. - May 26, 2026) - Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a cannabis e-commerce and distribution
PMET Resources Receives Government-Backed Letters of Support for Shaakichiuwaanaan Financing
07:00am, Tuesday, 19'th May 2026
MONTREAL, May 19, 2026 /PRNewswire/ - May 19, 2026 – Sydney, Australia Highlights PMET has received non-binding letters of support from Export Development Canada ("EDC"), Germany's KfW IPEX-Bank and
Europe's chemical makers catch a break as Iran war hits Asian rivals
01:02am, Tuesday, 12'th May 2026
Europe's embattled chemicals industry is getting an unexpected lift from the Iran war, as supply disruptions raise costs for Asian rivals and customers prioritise reliability over price.
Top Performing Leveraged/Inverse ETFs: 04/12/2026
04:02pm, Wednesday, 15'th Apr 2026
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Emerging Market Bulls Rejoicing, But Will It Last?
01:11pm, Thursday, 12'th Mar 2026
Emerging markets (EM) are undergoing a decisive shift in the early innings of 2026. Where do bulls and bears go from here?
Everpure Expands EDC With ActiveCluster for File Data Mobility
10:56am, Thursday, 12'th Mar 2026
PSTG unveils ActiveCluster for file, enabling policy-driven data mobility across storage fleets to keep enterprise data continuously available for AI workloads.
Adoption of Datatrak's eClinical solution enables CRO to actively manage all clinical trial data, processes, and documents on a single platform and dashboard with the first true eSource solution that
4 Leveraged ETFs That Could Benefit From Rate Cuts
12:39pm, Thursday, 11'th Sep 2025
If the CME FedWatch Tool is correct, then there's a 90% chance the U.S. Federal Reserve institutes a rate cut of 25 basis points. It should result in positive moves for a market that's been expecting
MustGrow Biologics receives $2M line of credit guaranteed by EDC
08:24am, Wednesday, 10'th Sep 2025
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced that it has secured a $2.0 million line of credit (LOC) with Canadian Imperial Bank of Commerce, which is guaranteed by Canada's Export D
MustGrow Secures $2 Million Line of Credit with CIBC; Guaranteed by EDC
07:00am, Wednesday, 10'th Sep 2025
Saskatoon, Saskatchewan--(Newsfile Corp. - September 10, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce it has secured a $
Emerging Markets No Longer a Contrarian Play? If So, 3X Your Exposure
06:33pm, Tuesday, 02'nd Sep 2025
A post-pandemic rally followed by an extended decline has been putting investors off emerging markets (EM) assets, but the tide could be turning in their favor. If so, traders may want to add leverage
Add Juice to Already-Hot Emerging Market Trade
08:48am, Tuesday, 26'th Aug 2025
Following what to many investors felt like an eternity of underperformance, emerging market stocks have come roaring back to life in 2025. As of August 15, the widely observed MSCI Emerging Markets In
Weakening Dollar Puts This Emerging Market ETF in Play
10:15am, Monday, 30'th Jun 2025
A weakening greenback could put emerging markets (EM) in the green. The anticipation of Fed easing and a confluence of other factors can make the Direxion Daily MSCI Emerging Markets Bull 3X Shares (E
Emerging Markets Could Be a Contrarian Play Amid U.S. Volatility
09:38am, Tuesday, 06'th May 2025
Emerging markets (EM) began to garner interest again as it appeared that forthcoming rate cuts could tamp down the strength of the U.S. dollar. But tariffs may have stifled a potential rally.
Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment
08:15am, Tuesday, 01'st Apr 2025
The clinical trial is designed to evaluate the safety, tolerability and efficacy of Clearmind's innovative, psychedelic-derived, MEAI-based compound in individuals with alcohol addiction
Sign In
Buy EDC